AKR1C3 is a biomarker and druggable target for oropharyngeal tumors
Caterina Peraldo‐Neia, Paola Ostano, Maurizia Mello‐Grand, Francesca Guana, Ilaria Gregnanin, Donatella Boschi, Simonetta Oliaro‐Bosso, Agnese Chiara Pippione, Andrea Carenzo, Loris De Cecco, Stefano Cavalieri, Arianna Micali, Federica Perrone, Gianluca Averono, Paolo Bagnasacco, R Dosdegani, Laura Masini, Marco Krengli, Paolo Aluffi-Valletti, Guido Valente, Giovanna Chiorino
Topics & Concepts
Cancer researchBiomarkerCisplatinGeneDruggabilityOncologyHead and neck squamous-cell carcinomaMedicineCohortBiologyInternal medicineRadiation therapyHead and neck cancerGeneticsChemotherapyAldose Reductase and TaurinePeptidase Inhibition and AnalysisSignaling Pathways in Disease